Document Detail

Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema.
MedLine Citation:
PMID:  19309368     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Atopic eczema (AE) is a common multifactorial chronic skin disease associated with a defective skin barrier and increased susceptibility to skin infections. The human cathelicidin LL-37 plays a role in the host defence of skin. Studies have demonstrated deficient expression of LL-37 in skin of AE patients. OBJECTIVES: The aim of this study was to investigate the expression of LL-37 in lesional skin compared with nonlesional skin in patients with different severity of AE, patients with other eczema and healthy subjects. METHODS: Twenty patients with AE, four patients with other eczema and 10 healthy subjects were included. Severity of AE was graded using SCORing of atopic dermatitis (SCORAD). Skin biopsies were taken from lesional and nonlesional skin from all patients and from skin of healthy controls. The levels of LL-37 mRNA were analysed by quantitative reverse transcriptase-polymerase chain reaction. Evaluation of dermal and epidermal protein expression of LL-37 and the degree of inflammation was performed by immunohistochemical stainings. RESULTS: Patients with AE and patients with other eczema had significantly (P < 0.05) higher levels of LL-37 in lesional skin than in nonlesional skin. The expression of LL-37 was not statistically associated to severity of AE valued by SCORAD. Nonlesional skin from patients did not differ from skin of healthy subjects in terms of LL-37 expression. In the presence of epidermal injury or vesicles the LL-37 peptide was always detected. CONCLUSIONS: Patients with AE exhibit enhanced expression of LL-37 in lesional skin compared with nonlesional, suggesting a role of LL-37 in AE that might be associated with the process of re-epithelialization.
N Ballardini; C Johansson; G Lilja; M Lindh; Y Linde; A Scheynius; B Agerberth
Related Documents :
20921748 - Direct immunofluorescence in lesional and uninvolved skin in dle.
8772778 - The epithelioid blue nevus. a multicentric familial tumor with important associations, ...
21557718 - Fecal eosinophil cationic protein as a marker of active disease and treatment outcome i...
16464228 - Dermatological manifestations in primary biliary cirrhosis patients: a case control study.
20238218 - Sexual functions in ankylosing spondylitis.
17967828 - 'unexpected' sudden death avoided by implantable cardioverter defibrillator in emery dr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-03-20
Journal Detail:
Title:  The British journal of dermatology     Volume:  161     ISSN:  1365-2133     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-09     Completed Date:  2009-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  40-7     Citation Subset:  IM    
Department of Clinical Science, Sach's Children's Hospital, Södersjukhuset, 118 83 Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cathelicidins / genetics,  metabolism*
Dermatitis, Atopic / immunology*,  metabolism,  pathology
Middle Aged
RNA, Messenger / metabolism
Reverse Transcriptase Polymerase Chain Reaction
Young Adult
Reg. No./Substance:
0/Cathelicidins; 0/RNA, Messenger; 0/antimicrobial peptide LL-37

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intense pulsed light vs. long-pulsed dye laser treatment of telangiectasia after radiotherapy for br...
Next Document:  Nonlinear spectral imaging of human hypertrophic scar based on two-photon excited fluorescence and s...